Dissemination of Escherichia coli producing AmpC-type beta-lactamase (CMY-11) in Korea

Int J Antimicrob Agents. 2004 Oct;24(4):320-6. doi: 10.1016/j.ijantimicag.2004.03.023.

Abstract

Among the 51 clinical isolates collected from a university hospital in Korea, nine isolates were resistant to cephamycins. Nine isolates were shown to produce CMY-11 and these also included three isolates producing TEM-1. The results from ERIC-PCR revealed that dissemination of CMY-11 was due to outbreaks of resistant species and to the intra-species spread of resistance to cephamycins in Korea. CMY-11 beta-lactamase genes from nine clinical isolates that were responsible for resistance to cephamycins (cefoxitin and cefotetan), amoxicillin, cephalothin and amoxicillin-clavulanic acid, were cloned and characterised. A sequence identical to the common regions in In6, In7 and a novel integron from pSAL-1 was found upstream from bla(CMY-11) gene at nucleotide 1-71. Eighteen nucleotides between position 71 and 72 were inserted into the bla(CMY-11) gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Proteins / biosynthesis
  • Bacterial Proteins / genetics*
  • Base Sequence
  • DNA Primers
  • DNA, Bacterial / genetics
  • Escherichia coli / classification
  • Escherichia coli / enzymology*
  • Escherichia coli / isolation & purification
  • Korea
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • beta-Lactamases / biosynthesis
  • beta-Lactamases / genetics*

Substances

  • Bacterial Proteins
  • DNA Primers
  • DNA, Bacterial
  • AmpC beta-lactamases
  • beta-Lactamases